| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/16/2006 | US20060035833 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035832 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035831 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035830 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035299 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 02/16/2006 | US20060035229 Have 5'-terminal or 3'-terminal areas incorporated stably into the metal oxide layer; freely movable orientation of areas of the unincorporated nucleic acids relative to the metal surface is provide mobility and are are accessible optimally for subsequent processes; coated with uniform orientation |
| 02/16/2006 | US20060035008 Edible film containing food acid |
| 02/16/2006 | US20060034951 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/16/2006 | US20060034948 Method for treating an environment that may be or is contaminated with an undesirable bacterial, virus and or spore |
| 02/16/2006 | US20060034939 Body cavity washer, device for washing body cavity and method of washing body cavity |
| 02/16/2006 | US20060034937 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 02/16/2006 | US20060034936 Sensate compositions and delivery systems therefor |
| 02/16/2006 | US20060034935 Compositions and methods for treating excessive bleeding |
| 02/16/2006 | US20060034934 Agglomeration of sterol particles |
| 02/16/2006 | US20060034933 Freeze-dried lecithin nanometer powder injection of ursolic acid and its preparation method |
| 02/16/2006 | US20060034932 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060034931 Solvent-assisted loading of therapeutic agents |
| 02/16/2006 | US20060034930 includes porous carrier formed from lyophilized hydrogel; once exposed to bodily fluids, carrier expands as lyophilized material hydrates to facilitate rapid hemostasis of puncture; when plug is placed into puncture natural wetting of plug by bodily fluids causes precursors to react and form adhesive |
| 02/16/2006 | US20060034929 Sustained release drug delivery devices with prefabricated permeable plugs |
| 02/16/2006 | US20060034928 Tablet comprising cetirizine and pseudoephedrine |
| 02/16/2006 | US20060034927 Means of delivering drugs in an ascending zero order release pattern |
| 02/16/2006 | US20060034926 Controlled release system |
| 02/16/2006 | US20060034925 Tumor targeting drug-loaded particles |
| 02/16/2006 | US20060034924 Mesostructured silica/block copolymer monoliths as a controlled release device and methods of manufacture |
| 02/16/2006 | US20060034923 Pharmaceutical compositions for controlled release delivery of biologically active compounds |
| 02/16/2006 | US20060034922 Controlled release metformin compositions |
| 02/16/2006 | US20060034921 Effervescent bisphosphonate formulation |
| 02/16/2006 | US20060034920 Effervescent formulations of oxytocin |
| 02/16/2006 | US20060034919 High ibuprofen content granules and their preparation and their use in pharmaceutical dosage forms |
| 02/16/2006 | US20060034918 Buoyant formulations of betaine |
| 02/16/2006 | US20060034917 Coating of tablet cores |
| 02/16/2006 | US20060034915 Dexamethasone-containing formulations for oral administration as well the process for manufacturing required therefor |
| 02/16/2006 | US20060034914 Direct compression polymer tablet core |
| 02/16/2006 | US20060034913 Multiplex drug delivery device |
| 02/16/2006 | US20060034911 New oral immediated release dosage form |
| 02/16/2006 | US20060034910 Pharmaceutical composition for extended release of phenytoin sodium |
| 02/16/2006 | US20060034909 Protein and peptide delivery to mammalian cells in vitro |
| 02/16/2006 | US20060034908 Manufacturing process for liposomal preparations |
| 02/16/2006 | US20060034907 Method of manufacturing pharmaceutical preparations containing liposomes |
| 02/16/2006 | US20060034906 Treatment of lung diseases and pre-lung disease conditions |
| 02/16/2006 | US20060034905 Adhesive composition |
| 02/16/2006 | US20060034904 Transdermal delivery using emcapsulated agent activated by ultrasound and or heat |
| 02/16/2006 | US20060034898 Method for using FIFRA-exempt substances, materials exhibiting antimicrobial, insecticidal, biocidal and/or odor controlling properties having one or more of these substances coated thereon and/or incorporated therein, and products that are made using these materials |
| 02/16/2006 | US20060034897 Delivery system for two or more active components as part of an edible composition |
| 02/16/2006 | US20060034895 Supplement food for low blood glucose recovery |
| 02/16/2006 | US20060034894 Warming compositions and delivery systems therefor |
| 02/16/2006 | US20060034887 Implantable structure for prolonged and controlled release of an active principle |
| 02/16/2006 | US20060034885 Medical use of aglycon geniposidic acid |
| 02/16/2006 | US20060034873 Palatable suspending vehicle for pharmaceutical ingredients |
| 02/16/2006 | US20060034872 Compositions and methods for preventing abuse of orally administered medications |
| 02/16/2006 | US20060034869 Drug for treating liver diseases with the use of hollow protein nanoparticles |
| 02/16/2006 | US20060034865 Soluble MHC artificial antigen presenting cells |
| 02/16/2006 | US20060034863 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 02/16/2006 | US20060034858 A beta or an immunogenic fragment thereof presented by a virus or bacteria as part of an immunogenic composition effective to induce an immunogenic response comprising antibodies against A beta |
| 02/16/2006 | US20060034855 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 02/16/2006 | US20060034827 Stabilized liquid anti-rsv antibody formulations |
| 02/16/2006 | US20060034824 Pharmaceutical composition comprising carriers for products |
| 02/16/2006 | US20060034822 Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eye |
| 02/16/2006 | US20060034818 Placental alkaline phosphatase to control diabetes |
| 02/16/2006 | US20060034816 comprises oxidoreductase enzyme in hydrated condition that catalyses conversion of atmospheric oxygen to hydrogen peroxide for transmittal through the dressing to the skin |
| 02/16/2006 | US20060034807 Innervated artificial tissues and uses thereof |
| 02/16/2006 | US20060034798 Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 02/16/2006 | US20060034797 Polymeric micromulsions |
| 02/16/2006 | US20060034772 Composition comprising low density microspheres |
| 02/16/2006 | US20060034770 Ultrasound contrast agents and process for the preparation thereof |
| 02/16/2006 | US20060033224 Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein |
| 02/16/2006 | US20060032607 Enhanced thawing of biopharmaceutical solutions using oscillatory motion |
| 02/16/2006 | DE29924843U1 Pellet for treating fungal infection comprises core coated with film of water soluble polymer and antifungal agent |
| 02/16/2006 | DE19628454B4 Rhamnolipid-Alginatpolymer-Komplex, mikrobiologisches Verfahren zu seiner Herstellung, Rhamnolipid-Alginatpolymer-Komplex-Zubereitungen und deren Verwendungen Rhamnolipid alginate complex, microbiological process for its production, rhamnolipid alginate complex compositions and their uses |
| 02/16/2006 | DE102004035938A1 Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil A process for the production of coated pharmaceutical forms having a stable active ingredient release profile |
| 02/16/2006 | DE102004035905A1 Magnesiumhaltiges Wundauflagematerial Magnesium containing wound dressing material |
| 02/16/2006 | DE102004035807A1 Device, useful to release/remove substances from inaccessible places, comprises goblet- and circular- shaped part intermediately arranged combined capsule, where one part is continuous magnetic and other is continuous- or soft magnetic |
| 02/16/2006 | DE102004034355A1 Kapsel zum Freisetzen von in ihr befindlichen Wirksoffen an definierten Orten in einem Körper Capsule to release of in their active open at defined locations in a body |
| 02/16/2006 | CA2736965A1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/16/2006 | CA2578574A1 Compositions for delivering highly water soluble drugs |
| 02/16/2006 | CA2578247A1 Coated vaginal devices for vaginal delivery of therapeutically effective and/ or health-promoting agents |
| 02/16/2006 | CA2576923A1 Vector |
| 02/16/2006 | CA2576642A1 Granules comprising a nsaid and a sugar alcohol made by melt extrusion |
| 02/16/2006 | CA2576386A1 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/16/2006 | CA2576385A1 Novel formulation for l-tryptophane comprising carbidopa/benserazide |
| 02/16/2006 | CA2575995A1 Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists |
| 02/16/2006 | CA2575739A1 Tablet coating composition |
| 02/16/2006 | CA2575617A1 Lysis/resealing process and device for incorporating an active ingredient in erythrocytes |
| 02/16/2006 | CA2575484A1 Sustained drug release composition demonstrating an ascending zero order release pattern, methods of manufacturing such a composition |
| 02/16/2006 | CA2573811A1 Stable particle formulations of erythropoietin receptor agonists |
| 02/16/2006 | CA2573810A1 Stable suspension formulations of erythropoietin receptor agonists |
| 02/16/2006 | CA2573686A1 Adhesive containing wound closure device and method |
| 02/16/2006 | CA2573668A1 Ophthalmic compositions and methods for treating ophthalmic conditions |
| 02/16/2006 | CA2573583A1 Coated vaginal device for delivery of anti-migraine and anti-nausea drugs and a method for treatment of migraine and nausea |
| 02/16/2006 | CA2573386A1 Composition for promoting vascular smooth muscle relaxation |
| 02/16/2006 | CA2573341A1 Ceramic structures for prevention of drug diversion |
| 02/16/2006 | CA2573316A1 Novel fenofibrate formulations and related methods of treatment |
| 02/16/2006 | CA2572868A1 Long-acting colloidal insulin formulation and preparation thereof |
| 02/16/2006 | CA2572865A1 Compositions and methods of use for treatment of mammalian diseases |
| 02/16/2006 | CA2572864A1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/16/2006 | CA2570877A1 Topical antiviral formulations |
| 02/16/2006 | CA2570863A1 Compositions containing nicorandil, preparation method and use |
| 02/15/2006 | EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/15/2006 | EP1625866A2 Enhanced thawing of biopharmaceutical solutions using oscillatory motion |
| 02/15/2006 | EP1625850A1 Immunostimulant |